Mamidipudi V - Search Results

1

Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.

Eve HE, Carey S, Richardson SJ, Heise CC, Mamidipudi V, Shi T, Radford JA, Auer RL, Bullard SH, Rule SA. Eve HE, et al. Among authors: mamidipudi v. Br J Haematol. 2012 Oct;159(2):154-63. doi: 10.1111/bjh.12008. Epub 2012 Aug 9. Br J Haematol. 2012. PMID: 22881386 Free article. Clinical Trial.

2

The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.

Buglio D, Mamidipudi V, Khaskhely NM, Brady H, Heise C, Besterman J, Martell RE, MacBeth K, Younes A. Buglio D, et al. Among authors: mamidipudi v. Br J Haematol. 2010 Nov;151(4):387-96. doi: 10.1111/j.1365-2141.2010.08342.x. Epub 2010 Sep 29. Br J Haematol. 2010. PMID: 20880107 Free PMC article.

3

Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells.

Mamidipudi V, Shi T, Brady H, Surapaneni S, Chopra R, Aukerman SL, Heise C, Sung V. Mamidipudi V, et al. Cancer Chemother Pharmacol. 2012 Apr;69(4):965-76. doi: 10.1007/s00280-011-1782-x. Epub 2011 Nov 26. Cancer Chemother Pharmacol. 2012. PMID: 22120960

4

A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways.

Mamidipudi V, Cartwright CA. Mamidipudi V, et al. Oncogene. 2009 Dec 17;28(50):4421-33. doi: 10.1038/onc.2009.293. Epub 2009 Sep 21. Oncogene. 2009. PMID: 19767770

5

RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints.

Mamidipudi V, Dhillon NK, Parman T, Miller LD, Lee KC, Cartwright CA. Mamidipudi V, et al. Oncogene. 2007 May 3;26(20):2914-24. doi: 10.1038/sj.onc.1210091. Epub 2006 Oct 30. Oncogene. 2007. PMID: 17072338

6

Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells.

Mamidipudi V, Miller LD, Mochly-Rosen D, Cartwright CA. Mamidipudi V, et al. Biochem Biophys Res Commun. 2007 Jan 12;352(2):423-30. doi: 10.1016/j.bbrc.2006.11.034. Epub 2006 Nov 15. Biochem Biophys Res Commun. 2007. PMID: 17118337 Free PMC article.

7

RACK1 inhibits the serum- and anchorage-independent growth of v-Src transformed cells.

Mamidipudi V, Chang BY, Harte RA, Lee KC, Cartwright CA. Mamidipudi V, et al. FEBS Lett. 2004 Jun 4;567(2-3):321-6. doi: 10.1016/j.febslet.2004.03.125. FEBS Lett. 2004. PMID: 15178345 Free article.

8

RACK1 regulates G1/S progression by suppressing Src kinase activity.

Mamidipudi V, Zhang J, Lee KC, Cartwright CA. Mamidipudi V, et al. Mol Cell Biol. 2004 Aug;24(15):6788-98. doi: 10.1128/MCB.24.15.6788-6798.2004. Mol Cell Biol. 2004. PMID: 15254245 Free PMC article.

9

The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor.

Wooten MW, Seibenhener ML, Mamidipudi V, Diaz-Meco MT, Barker PA, Moscat J. Wooten MW, et al. Among authors: mamidipudi v. J Biol Chem. 2001 Mar 16;276(11):7709-12. doi: 10.1074/jbc.C000869200. Epub 2001 Jan 22. J Biol Chem. 2001. PMID: 11244088 Free article.

10

Dual role for p75(NTR) signaling in survival and cell death: can intracellular mediators provide an explanation?

Mamidipudi V, Wooten MW. Mamidipudi V, et al. J Neurosci Res. 2002 May 15;68(4):373-84. doi: 10.1002/jnr.10244. J Neurosci Res. 2002. PMID: 11992464 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters